Consultation on the third legislative review of the Tobacco and Vaping Products Act

This review, the third legislative review of the Tobacco and Vaping Products Act (TVPA), will focus on compliance and enforcement issues identified in the final reports for the first and the second reviews. This includes a potential need for additional or enhanced tools for a progressive enforcement approach to help address non-compliance.

This consultation is seeking comments regarding the compliance and enforcement of the TVPA. Submissions will be summarized in a final report; however, comments will not be attributed to any specific individual or organization. This final report will be tabled in Parliament and will be made public on Canada.ca.

Join in: how to participate

A key part of the legislative review is seeking the perspectives of Canadians, experts, and other stakeholders as they relate to the compliance and enforcement of the TVPA, including your ideas, your experiences and your perspectives on compliance and enforcement challenges related to tobacco and vaping products both online and in physical points of sale.

You are invited to participate in this consultation. A discussion paper, focusing on compliance and enforcement issues identified in the final reports of the first review and the second review, is available for added context.

You are also encouraged to submit any data and evidence that you may have to support your responses.

The consultation period ends September 12, 2025.

You may participate by sending your written submission to: legislativereviewtvpa.revisionlegislativeltpv@hc-sc.gc.ca

You must declare any perceived or actual conflicts of interest with the tobacco industry when providing a submission to this consultation. If you are part of the tobacco industry, an affiliated organization, an individual acting on its behalf, or otherwise support the interests of the tobacco industry, you must clearly state this in your submission.

Health Canada is also interested in being made aware of perceived or actual conflicts of interest with the vaping and/or pharmaceutical industry. Therefore, please declare any perceived or actual conflicts of interest, if applicable, when providing input. If you are a member of the vaping industry, pharmaceutical industry, an affiliated organization, or an individual acting on their behalf, you are asked to clearly state so in your submission.

Who is the focus of this consultation

We are seeking comments from:

• The general public, including those with lived and living experiences of tobacco and vaping use
• First Nations, Inuit and Métis peoples and organizations
• Experts in the field of regulations and compliance and enforcement
• Law enforcement professionals
• Provincial and Territorial governments
• Health partners
• Tobacco control experts - domestic and international
• Non-governmental organizations
• Academics
• Youth
• Interested members of the tobacco and vaping industries

Related information

Canada introduced new measures to regulate tobacco and vaping products and a new tobacco control strategy in 2018. The Tobacco Act of 1997 was amended and renamed the Tobacco and Vaping Products Act (TVPA) and Canada's Tobacco Strategy (CTS) was launched to address tobacco use in Canada. CTS sets an ambitious target to reduce the prevalence of tobacco use to less than 5 percent by 2035. Health Canada has set interim targets of reducing tobacco use among those 18 years and older to 11 percent by 2025 and 9 percent by 2030. It also has set a target of reducing vaping use among those aged 12 to 17 to below 10 percent by 2025.

To achieve this target, CTS aims to help Canadians quit tobacco, protect youth and people who do not use tobacco from nicotine addiction. Additionally, it aims to support First Nations, Inuit and Métis organizations to develop and implement their own self-determined, culturally appropriate and distinct approaches to reducing commercial tobacco use based on their own needs and priorities, and strengthen science, surveillance, and partnerships.

The TVPA includes a requirement to undertake a legislative review of its provisions and operation three years after coming-into-force, and every two years thereafter. This public consultation will help support the evidence-based analysis and review of the legislation.

Contact us

Manager, Legislative Review
Office of Policy and Strategic Planning
Tobacco Control Directorate
Controlled Substances and Cannabis Branch, Health Canada
5004A – 405 Terminal Avenue
Ottawa, Ontario, K1G 0Z3
Email: legislativereviewtvpa.revisionlegislativeltpv@hc-sc.gc.ca